Documentos relacionados

1. [Glioblastoma, IDH-Wildtype].
2. Expression of pyruvate carboxylase in cultured human astrocytoma, glioblastoma and neuroblastoma cells.
3. Role of CDKN2A deletion in grade 2/3 IDH-mutant astrocytomas: need for selective approach in resource-constrained settings.
4. Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity.
5. Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.
6. [Prognosis of overall and disease-free survival in patients with grade 3 astrocytomas (anaplastic astrocytoma, WHO 2016)].
7. A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery.
8. Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma.
9. Endoscopic resection of thalamic lesions via supracerebellar infratentorial approach: a case series and technical note.
10. Ion Channels in Glioma Malignancy.